Average Co-Inventor Count = 4.14
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Transtech Pharma, Inc. (7 from 49 patents)
2. University of Pennsylvania (5 from 2,595 patents)
3. High Point Pharmaceuticals, LLC (3 from 50 patents)
4. Rubicon Scientific LLC (3 from 3 patents)
5. Seal Rock Technologies Incorporated (3 from 3 patents)
6. The Procter Gamble Company (2 from 17,164 patents)
7. Vtv Therapeutics LLC (2 from 52 patents)
8. Other (1 from 832,680 patents)
9. Regeneron Pharmaceuticals, Inc. (1 from 1,342 patents)
10. International Flora Technologies, Ltd. (1 from 27 patents)
29 patents:
1. 10363241 - Substituted imidazole derivatives and methods of use thereof
2. 9598375 - Substituted imidazole derivatives and methods of use thereof
3. 9045461 - Phenyl-heteroaryl derivatives and methods of use thereof
4. 8946259 - Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
5. 8741900 - Phenyl-heteroaryl derivatives and methods of use thereof
6. 8598353 - Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors
7. 8580833 - Substituted imidazole derivatives and methods of use thereof
8. 8431575 - Phenyl-heteroaryl derivatives and methods of use thereof
9. 7893267 - Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors
10. 7737285 - Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
11. 7723536 - Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
12. 7714013 - Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
13. 7361678 - Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
14. 7052712 - Animal feeds including actives and methods of preparing same
15. 7052705 - Anti-angiogenic peptides